Trail PA, Willner D, Lasch SJ, Henderson AJ, Hofstead S, Casazza AM, Firestone RA, Hellström I, Hellström KE (July 1993). "Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates". Science. 261 (5118): 212–5. Bibcode:1993Sci...261..212T. doi:10.1126/science.8327892. PMID8327892.
harvard.edu
ui.adsabs.harvard.edu
Trail PA, Willner D, Lasch SJ, Henderson AJ, Hofstead S, Casazza AM, Firestone RA, Hellström I, Hellström KE (July 1993). "Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates". Science. 261 (5118): 212–5. Bibcode:1993Sci...261..212T. doi:10.1126/science.8327892. PMID8327892.
nih.gov
pubmed.ncbi.nlm.nih.gov
Trail PA, Willner D, Lasch SJ, Henderson AJ, Hofstead S, Casazza AM, Firestone RA, Hellström I, Hellström KE (July 1993). "Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates". Science. 261 (5118): 212–5. Bibcode:1993Sci...261..212T. doi:10.1126/science.8327892. PMID8327892.
Sjögren HO, Isaksson M, Willner D, Hellström I, Hellström KE, Trail PA (October 1997). "Antitumor activity of carcinoma-reactive BR96-doxorubicin conjugate against human carcinomas in athymic mice and rats and syngeneic rat carcinomas in immunocompetent rats". Cancer Research. 57 (20): 4530–6. PMID9377565.